Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma ; volume:10 ; number:1 ; day:5 ; month:1 ; year:2017 ; pages:1-11 ; date:12.2017
Journal of hematology & oncology ; 10, Heft 1 (5.1.2017), 1-11, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Feng, Kai-chao
- Beteiligte Personen und Organisationen
-
Guo, Ye-lei
Liu, Yang
Dai, Han-ren
Wang, Yao
Lv, Hai-yan
Huang, Jian-hua
Yang, Qing-ming
Han, Wei-dong
SpringerLink (Online service)
- DOI
-
10.1186/s13045-016-0378-7
- URN
-
urn:nbn:de:1111-201702216353
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Feng, Kai-chao
- Guo, Ye-lei
- Liu, Yang
- Dai, Han-ren
- Wang, Yao
- Lv, Hai-yan
- Huang, Jian-hua
- Yang, Qing-ming
- Han, Wei-dong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Chimeric toxins for specific targeting of cancer cells
Imaging and selective elimination of glioblastoma stem cells with theranostic near-infrared-labeled CD133-specific antibodies
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
Construction and evaluation of a novel humanized HER2-specific chimeric receptor
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery
Chimeric toxins for specific targeting of cancer cells
Imaging and selective elimination of glioblastoma stem cells with theranostic near-infrared-labeled CD133-specific antibodies
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
Construction and evaluation of a novel humanized HER2-specific chimeric receptor
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery
Chimeric toxins for specific targeting of cancer cells
Imaging and selective elimination of glioblastoma stem cells with theranostic near-infrared-labeled CD133-specific antibodies
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
Construction and evaluation of a novel humanized HER2-specific chimeric receptor
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma